Jean-Michel Dogné, pharmacovigilance expert at the FAMHP, is appointed member of the World Health Organization's Global Advisory Committee on Vaccine Safety

Jean-Michel Dogné has been putting his expertise at the service of the FAMHP for many years. The Belgian expertise in vaccines is recognised worldwide with his recent appointment as a member of the Global Advisory Committee on Vaccine Safety (GACVS) of the World Health Organisation (WHO).

Jean-Michel Dogné is director of the Department Pharmacy at the University of Namur en pharmacovigilance expert at the service of the FAMHP. The FAMHP welcomes his appointment as a member of the WHO's GACVS. As the Belgian competent authority, our agency pays particular attention to continuously developing its network of partnerships at international level. The appointment of one of our experts to the WHO is an positive sign of significant recognition of the Belgian expertise acquired within the FAMHP and is essential in the development and in the activities of our spearhead Vaccines.

The GACVS was set up in 1999 to respond promptly, efficiently and with scientific rigour to vaccine safety issues of potential global importance. The GACVS provides independent and scientific advice on vaccine safety issues of global importance with the potential to affect in the short and long term national immunisation programmes. The committee is made up of fifteen members. These members come from all around the world and are recognised experts in various fields such as epidemiology, statistics, paediatrics, internal medicine, pharmacology, toxicology, infectious diseases, public health, immunology and autoimmunity, vaccinology, pathology, ethics, neurology, pharmaceutical regulation and vaccine safety.

Last updated on
04/02/2020